These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2203306)

  • 1. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
    Smith CE; Tillman BS; Howell AW; Longfield RN; Jorgensen JH
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1290-3. PubMed ID: 2203306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
    de Champs C; Guelon D; Joyon D; Sirot D; Chanal M; Sirot J
    Infection; 1991; 19(3):181-3. PubMed ID: 1889874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Szabó D; Máthé A; Filetóth Z; Anderlik P; Rókusz L; Rozgonyi F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1287-91. PubMed ID: 11257049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli.
    Sirot D; De Champs C; Chanal C; Labia R; Darfeuille-Michaud A; Perroux R; Sirot J
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1576-81. PubMed ID: 1929328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
    Urban C; Mariano N; Rahman N; Queenan AM; Montenegro D; Bush K; Rahal JJ
    Microb Drug Resist; 2000; 6(4):297-303. PubMed ID: 11272258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
    Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.
    Arlet G; Sanson-le Pors MJ; Rouveau M; Fournier G; Marie O; Schlemmer B; Philippon A
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):797-803. PubMed ID: 2086215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes.
    Einhorn AE; Neuhauser MM; Bearden DT; Quinn JP; Pendland SL
    Pharmacotherapy; 2002 Jan; 22(1):14-20. PubMed ID: 11794426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
    Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
    Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
    Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
    Ronco E; Lawrence C; Nauciel C
    Pathol Biol (Paris); 1998 Oct; 46(8):651-5. PubMed ID: 9871937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 18. Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit.
    Royle J; Halasz S; Eagles G; Gilbert G; Dalton D; Jelfs P; Isaacs D
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F64-8. PubMed ID: 10325816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
    Wong-Beringer A; Hindler J; Loeloff M; Queenan AM; Lee N; Pegues DA; Quinn JP; Bush K
    Clin Infect Dis; 2002 Jan; 34(2):135-46. PubMed ID: 11740699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.